August 30, 2014 9:56 PM ET

Healthcare Equipment and Supplies

Company Overview of Data Sciences International, Inc.

Company Overview

Data Sciences International, Inc., a biomedical research company, designs and manufactures implantable telemetry devices for physiologic monitoring. The company provides implantable telemetry, external telemetry, software, hardwired amplification, respiratory products, glucose monitoring products, and infusion pumps. Its products are used in neuroscience, cardiovascular, respiratory, electrophysiology, chemical and biological defense, infusion, integrated pharmacology, and unique applications. The company also offers scientific services, such as surgical, data analysis, and validation assistance. It serves pharmaceuticals, academia, biological and chemical defense, medical device, and govern...

119 14th Street NW

Suite 100

St. Paul, MN 55112

United States

Founded in 1984

Phone:

651-481-7400

Fax:

651-481-4717

Key Executives for Data Sciences International, Inc.

Chief Executive Officer
Age: 67
General Manager
Compensation as of Fiscal Year 2014.

Data Sciences International, Inc. Key Developments

Data Sciences International, Inc. Launches Telemetry Implant for Continuous Real-Time Glucose Measurement

Data Sciences International (DSI) has introduced the first-ever glucose telemetry implant for obtaining continuous, real-time measurements of blood glucose in laboratory animals. Because the sensor is placed directly into the bloodstream, researchers are now able to detect instantaneous changes in blood glucose, body temperature, and activity for 28 days or longer while reducing animal stress and measurement variability commonly associated with the use of glucose test strips. The Centers for Disease Control and Prevention (CDC) estimates that diabetes affects 26 million people in the U.S. alone, or 8.3% of the population. Diabetes is a major cause of heart disease, stroke, kidney failure, lower-limb amputations, and blindness. The National Institutes of Health (NIH) is providing an estimated $1 billion in funding for diabetes research in 2014. In addition, with nearly every major pharmaceutical company engaged in the development of new treatments for diabetes and metabolic disease, demand for better research instrumentation has also increased.

Bioanalytical Systems Inc. Announces Pivotal Study with Data Sciences International, Inc

Bioanalytical Systems Inc. announced that it is collaborating with Data Sciences International, Inc. to conduct study combining Bioanalytical Systems Inc.'s Culex-L automated sampling system with Data Sciences International, Inc.'s PhysioTel Digital. In this pivotal study, Bioanalytical Systems Inc.'s Culex-L automated in vivo sampling system will simultaneously collect biological samples at pre-programmed intervals while Data Sciences International, Inc. telemetry devices will collect heart rate, blood pressure and other cardiovascular information.

Similar Private Companies By Industry

Company Name Region
Aalnex, Inc. United States
NeuroAccess Technologies Inc. United States
Keller Medical, Inc. United States
RespCare, Inc. United States
Sentinelle Medical USA Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
January 7, 2014
Buxco Electronics, Inc.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Data Sciences International, Inc., please visit www.datasci.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.